Efficacy ketotifen corticosteroid-dependent idiopathic anaphylaxis potential benefit ketotifen treatment patients corticosteroid-dependent idiopathic anaphylaxis ketotifen open trial patients idiopathic anaphylaxis maintenance prednisone control disease double-blind trial reasons patient safety period management prednisone establishment minimal dose prednisone idiopathic anaphylaxis ketotifen cautious reduction prednisone prednisone requirement patients prednisone patients patients recurrent symptoms idiopathic anaphylaxis discontinuation ketotifen statistical analysis prednisone reduction significant significant benefit patients corticosteroid-dependent idiopathic anaphylaxis 